Dyne Therapeutics, Inc. has priced an upsized public offering of 18.980 million shares at $18.44 per share, raising $350 million. The offering is set to close on or around December 11, with underwriters having the option to purchase an additional 2.847 million shares at the same price.

Read more at Nasdaq: Dyne Therapeutics Prices Upsized Public Offering Of 18.98 Mln Shares